The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections
Open Access
- 29 April 2015
- journal article
- research article
- Published by Ecancer Global Foundation in ecancermedicalscience
- Vol. 9, 534
Abstract
Ecancermedicalscience is the peer-reviewed open access cancer journal founded by the European Institute of Oncology in Milan. We consider articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epideKeywords
This publication has 39 references indexed in Scilit:
- The human papillomavirus family and its role in carcinogenesisSeminars in Cancer Biology, 2014
- Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trialThe Lancet Oncology, 2013
- Viral manipulation of cellular protein conjugation pathways: The SUMO lessonWorld Journal of Virology, 2013
- Human Papillomavirus Testing in the Prevention of Cervical CancerJNCI: Journal of the National Cancer Institute, 2011
- The Sensitivity and Specificity of p16INK4a Cytology vs HPV Testing for Detecting High-Grade Cervical Disease in the Triage of ASC-US and LSIL Pap Cytology ResultsAmerican Journal of Clinical Pathology, 2010
- Human papillomavirus oncoproteins: pathways to transformationNature Reviews Cancer, 2010
- p16INK4a immunostaining in cytological and histological specimens from the uterine cervix: A systematic review and meta-analysisCancer Treatment Reviews, 2009
- Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trialThe Lancet Oncology, 2008
- Concepts in sumoylation: a decade onNature Reviews Molecular Cell Biology, 2007
- SUMOMolecular Cell, 2005